These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1502 related items for PubMed ID: 9632134

  • 1. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
    Orend G, Hunter T, Ruoslahti E.
    Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
    [Abstract] [Full Text] [Related]

  • 2. Adhesion-dependent control of cyclin E/cdk2 activity and cell cycle progression in normal cells but not in Ha-ras transformed NRK cells.
    Carstens CP, Krämer A, Fahl WE.
    Exp Cell Res; 1996 Nov 25; 229(1):86-92. PubMed ID: 8940252
    [Abstract] [Full Text] [Related]

  • 3. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
    Cereseto A, Washington Parks R, Rivadeneira E, Franchini G.
    Oncogene; 1999 Apr 15; 18(15):2441-50. PubMed ID: 10229195
    [Abstract] [Full Text] [Related]

  • 4. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ, Kiyokawa H, Yan JS, Rubin MS, Giordano A, DeBlasio A, Bottega S, Wong B, Mendelsohn J, Koff A.
    Cell Growth Differ; 1996 Feb 15; 7(2):135-46. PubMed ID: 8822197
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL, Buffolino P, Kopman C, Nathanson L.
    Exp Cell Res; 1995 Nov 15; 221(1):92-102. PubMed ID: 7589260
    [Abstract] [Full Text] [Related]

  • 6. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S, Lowe M, Herliczek TW, Keyomarsi K.
    Oncogene; 1998 Nov 05; 17(18):2393-402. PubMed ID: 9811471
    [Abstract] [Full Text] [Related]

  • 7. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.
    Tsihlias J, Zhang W, Bhattacharya N, Flanagan M, Klotz L, Slingerland J.
    Oncogene; 2000 Feb 03; 19(5):670-9. PubMed ID: 10698512
    [Abstract] [Full Text] [Related]

  • 8. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
    Akiyama T, Yoshida T, Tsujita T, Shimizu M, Mizukami T, Okabe M, Akinaga S.
    Cancer Res; 1997 Apr 15; 57(8):1495-501. PubMed ID: 9108451
    [Abstract] [Full Text] [Related]

  • 9. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M, Estanyol JM, Serratosa J, Agell N, Bachs O.
    Hepatology; 1999 Feb 15; 29(2):385-95. PubMed ID: 9918914
    [Abstract] [Full Text] [Related]

  • 10. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C, Donovan J, Bhattacharya N, Stampfer M, Worland P, Slingerland J.
    Oncogene; 2000 Nov 09; 19(47):5314-23. PubMed ID: 11103932
    [Abstract] [Full Text] [Related]

  • 11. Loss of cell cycle control by deregulation of cyclin-dependent kinase 2 kinase activity in Evi-1 transformed fibroblasts.
    Kilbey A, Stephens V, Bartholomew C.
    Cell Growth Differ; 1999 Sep 09; 10(9):601-10. PubMed ID: 10511310
    [Abstract] [Full Text] [Related]

  • 12. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G, Barkan R, Popov B, Nikolsky N, Chang LS.
    Exp Cell Res; 2000 Aug 25; 259(1):35-53. PubMed ID: 10942577
    [Abstract] [Full Text] [Related]

  • 13. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes.
    Ravanko K, Järvinen K, Paasinen-Sohns A, Hölttä E.
    Cancer Res; 2000 Sep 15; 60(18):5244-53. PubMed ID: 11016654
    [Abstract] [Full Text] [Related]

  • 14. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
    Morris TA, DeLorenzo RJ, Tombes RM.
    Exp Cell Res; 1998 May 01; 240(2):218-27. PubMed ID: 9596994
    [Abstract] [Full Text] [Related]

  • 15. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T.
    J Immunol; 1998 Jan 15; 160(2):770-7. PubMed ID: 9551912
    [Abstract] [Full Text] [Related]

  • 16. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.
    Vlach J, Hennecke S, Alevizopoulos K, Conti D, Amati B.
    EMBO J; 1996 Dec 02; 15(23):6595-604. PubMed ID: 8978686
    [Abstract] [Full Text] [Related]

  • 17. Insensitivity to growth inhibition by TGF-beta1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells.
    Cipriano SC, Chen YQ.
    Oncogene; 1998 Sep 24; 17(12):1549-56. PubMed ID: 9794232
    [Abstract] [Full Text] [Related]

  • 18. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
    Koga H, Sakisaka S, Harada M, Takagi T, Hanada S, Taniguchi E, Kawaguchi T, Sasatomi K, Kimura R, Hashimoto O, Ueno T, Yano H, Kojiro M, Sata M.
    Hepatology; 2001 May 24; 33(5):1087-97. PubMed ID: 11343236
    [Abstract] [Full Text] [Related]

  • 19. Dependence of cyclin E-CDK2 kinase activity on cell anchorage.
    Fang F, Orend G, Watanabe N, Hunter T, Ruoslahti E.
    Science; 1996 Jan 26; 271(5248):499-502. PubMed ID: 8560263
    [Abstract] [Full Text] [Related]

  • 20. Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours.
    Coppée F, Depoortere F, Bartek J, Ledent C, Parmentier M, Dumont JE.
    Oncogene; 1998 Aug 06; 17(5):631-41. PubMed ID: 9704929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 76.